Wednesday, 07 Apr 2021 07:52 AM MYT
The study by the University of Chile found inoculation to be 56.5 per cent effective in protecting recipients two weeks after the second dose, and 27.7 per cent effective within the first two weeks. Researchers looked at the combined effect of Coronavac, which accounts for about 93 per cent of doses being administered, and the Pfizer-BioNTech vaccine.
Like the rest of Latin America, the country has seen a steep rise in new infections and has surpassed the daily rate of the first wave last year, with more than 8,000 new cases per day.